Jing Liu
- Animal Science and Zoology top 1%
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 18
- Cancer Research top 5%
- Hematology top 2%
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 19
-
- Traditional Chinese Medicine Analysis 10
-
- Chronic Lymphocytic Leukemia Research 13
-
- HER2/EGFR in Cancer Research 13
-
- Lung Cancer Treatments and Mutations 12
-
- Monoclonal and Polyclonal Antibodies Research 10
- Journals
- Nature (1 paper)Angewandte Chemie International Edition (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jing Liu
237 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Animal Science and Zoology 429
- Molecular Biology 2.9k
- Cancer Research 548
- Hematology 368
- Complementary and alternative medicine 230
Countries citing papers authored by Jing Liu
This map shows the geographic impact of Jing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Liu more than expected).
Fields of papers citing papers by Jing Liu
This network shows the impact of papers produced by Jing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Liu. The network helps show where Jing Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 13 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 12 | |
| 15 | 2018 | 33 | |
| 16 | 2018 | 12 | |
| 17 | 2016 | 5 | |
| 18 | 2015 | 64 | |
| 19 | 2014 | 1 | |
| 20 | 2010 | 15 |
About Jing Liu
Jing Liu is a scholar working on Hematology, Complementary and alternative medicine and Genetics, having authored 251 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (19 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Chronic Lymphocytic Leukemia Research (13 papers), HER2/EGFR in Cancer Research (13 papers), Lung Cancer Treatments and Mutations (12 papers), Traditional Chinese Medicine Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Animal Science and Zoology (429 citations), Molecular Biology (2.9k citations) and Cancer Research (548 citations). Jing Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Baohua Kong, Qian Liu, Xiufang Xia, Qingsong Liu, Fengming Zou, Huamin Liang, Ziping Qi, Wenchao Wang, Ziyuan Wang and Chen Hu. Their work appears in journals such as Nature, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.